vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Cronos Group Inc. (CRON). Click either name above to swap in a different company.
Cronos Group Inc. is the larger business by last-quarter revenue ($44.5M vs $34.3M, roughly 1.3× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -4.1%, a 2.3% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs -3.2%). Cronos Group Inc. produced more free cash flow last quarter ($9.7M vs $-2.4M). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
CLFD vs CRON — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $44.5M |
| Net Profit | $-614.0K | $-1.8M |
| Gross Margin | 33.2% | 36.4% |
| Operating Margin | -5.3% | -16.8% |
| Net Margin | -1.8% | -4.1% |
| Revenue YoY | -3.2% | 47.0% |
| Net Profit YoY | 67.8% | -104.2% |
| EPS (diluted) | $-0.04 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $44.5M | ||
| Q3 25 | $23.4M | $36.3M | ||
| Q2 25 | $49.9M | $33.5M | ||
| Q1 25 | $47.2M | $32.3M | ||
| Q4 24 | $29.7M | $30.3M | ||
| Q3 24 | $5.6M | $34.3M | ||
| Q2 24 | $48.8M | $27.8M | ||
| Q1 24 | $36.9M | $25.3M |
| Q4 25 | $-614.0K | $-1.8M | ||
| Q3 25 | $-9.1M | $26.0M | ||
| Q2 25 | $1.6M | $-39.7M | ||
| Q1 25 | $1.3M | $6.1M | ||
| Q4 24 | $-1.9M | $43.7M | ||
| Q3 24 | — | $8.3M | ||
| Q2 24 | $-447.0K | $-8.8M | ||
| Q1 24 | $-5.9M | $-2.2M |
| Q4 25 | 33.2% | 36.4% | ||
| Q3 25 | 53.2% | 50.4% | ||
| Q2 25 | 30.5% | 43.4% | ||
| Q1 25 | 30.1% | 42.6% | ||
| Q4 24 | 29.2% | 35.7% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | 21.9% | 22.7% | ||
| Q1 24 | 7.7% | 17.7% |
| Q4 25 | -5.3% | -16.8% | ||
| Q3 25 | 10.3% | -1.4% | ||
| Q2 25 | 3.0% | -15.9% | ||
| Q1 25 | 0.6% | -12.6% | ||
| Q4 24 | -6.9% | -37.5% | ||
| Q3 24 | — | -98.2% | ||
| Q2 24 | -4.7% | -56.1% | ||
| Q1 24 | -26.4% | -63.1% |
| Q4 25 | -1.8% | -4.1% | ||
| Q3 25 | -38.8% | 71.4% | ||
| Q2 25 | 3.2% | -118.7% | ||
| Q1 25 | 2.8% | 19.0% | ||
| Q4 24 | -6.4% | 144.3% | ||
| Q3 24 | — | 24.4% | ||
| Q2 24 | -0.9% | -31.5% | ||
| Q1 24 | -16.0% | -8.9% |
| Q4 25 | $-0.04 | $-0.01 | ||
| Q3 25 | $-0.65 | $0.07 | ||
| Q2 25 | $0.11 | $-0.10 | ||
| Q1 25 | $0.09 | $0.02 | ||
| Q4 24 | $-0.13 | $0.12 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | $-0.04 | $-0.02 | ||
| Q1 24 | $-0.40 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $831.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $1.1B |
| Total Assets | $268.1M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $831.8M | ||
| Q3 25 | $106.0M | $824.2M | ||
| Q2 25 | $117.2M | $834.4M | ||
| Q1 25 | $112.0M | $837.8M | ||
| Q4 24 | $113.0M | $858.8M | ||
| Q3 24 | $129.0M | $862.0M | ||
| Q2 24 | $123.8M | $848.2M | ||
| Q1 24 | $142.9M | $855.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $1.1B | ||
| Q3 25 | $256.2M | $1.1B | ||
| Q2 25 | $264.5M | $1.1B | ||
| Q1 25 | $265.9M | $1.1B | ||
| Q4 24 | $267.4M | $1.1B | ||
| Q3 24 | $275.8M | $1.1B | ||
| Q2 24 | $274.6M | $1.1B | ||
| Q1 24 | $279.2M | $1.1B |
| Q4 25 | $268.1M | $1.2B | ||
| Q3 25 | $306.2M | $1.2B | ||
| Q2 25 | $314.7M | $1.2B | ||
| Q1 25 | $310.9M | $1.2B | ||
| Q4 24 | $303.2M | $1.2B | ||
| Q3 24 | $315.3M | $1.2B | ||
| Q2 24 | $318.1M | $1.1B | ||
| Q1 24 | $315.4M | $1.1B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $11.8M |
| Free Cash FlowOCF − Capex | $-2.4M | $9.7M |
| FCF MarginFCF / Revenue | -7.1% | 21.8% |
| Capex IntensityCapex / Revenue | 2.9% | 4.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $149.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $11.8M | ||
| Q3 25 | — | $13.3M | ||
| Q2 25 | $7.9M | $2.8M | ||
| Q1 25 | $3.0M | $-2.1M | ||
| Q4 24 | $7.2M | $7.7M | ||
| Q3 24 | $22.2M | $11.6M | ||
| Q2 24 | $4.0M | $1.7M | ||
| Q1 24 | $-5.7M | $-2.2M |
| Q4 25 | $-2.4M | $9.7M | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | $7.5M | $-1.0M | ||
| Q1 25 | $654.0K | $-17.4M | ||
| Q4 24 | $5.1M | $4.2M | ||
| Q3 24 | $18.2M | $5.2M | ||
| Q2 24 | $2.8M | $1.0M | ||
| Q1 24 | $-7.7M | $-3.9M |
| Q4 25 | -7.1% | 21.8% | ||
| Q3 25 | — | 24.3% | ||
| Q2 25 | 15.1% | -3.0% | ||
| Q1 25 | 1.4% | -53.8% | ||
| Q4 24 | 17.1% | 13.8% | ||
| Q3 24 | 323.0% | 15.1% | ||
| Q2 24 | 5.8% | 3.7% | ||
| Q1 24 | -20.8% | -15.5% |
| Q4 25 | 2.9% | 4.8% | ||
| Q3 25 | 2.0% | 12.3% | ||
| Q2 25 | 0.8% | 11.5% | ||
| Q1 25 | 5.1% | 47.3% | ||
| Q4 24 | 7.0% | 11.7% | ||
| Q3 24 | 71.4% | 18.7% | ||
| Q2 24 | 2.5% | 2.6% | ||
| Q1 24 | 5.3% | 6.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | -0.34× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLFD
Segment breakdown not available.
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
